ALS neuron damage reversed with new compound

New compound targets neurons that initiate voluntary movement After 60 days of treatment, diseased brain cells look like healthy cells More research needed before clinical trial can be initiated CHICAGO and EVANSTON— Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a…

Details

Pregnancy, stress, sleep issues, physiology among women’s unique cardiovascular concerns

DALLAS, Feb. 23, 2021 — Women face many female-specific risks for heart disease and stroke, including pregnancy, physical and emotional stress, sleep patterns and many physiological factors, according to multiple studies highlighted in this year’s Go Red for Women® special issue of the Journal of the American Heart Association, published online today. “Although cardiovascular disease…

Details

JDRF announces new Center of Excellence in New England to advance type 1 diabetes research

NEW YORK, NY, February 23, 2021–JDRF, the leading global organization funding type 1 diabetes (T1D) research, announces, in collaboration with the Harvard Stem Cell Institute, the launch of the JDRF Center of Excellence in New England. Led by Harvard Stem Cell Institute co-director Douglas Melton, Ph.D. and JDRF scientific staff leader Esther Latres, Ph.D., Assistant…

Details